Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic

The purpose of this study is to evaluate the effect of intravenous lidocaine infusion on pain and opioid dosage in patients undergoing single-port thoracoscopic surgery,and to evaluate the effects of perioperative catecholamine levels, extubation time, incidence of nausea and vomiting, patient satisfaction and hospital stay.

Visão geral do estudo

Status

Desconhecido

Condições

Descrição detalhada

The World Congress on Pain identified pain as the "fifth leading indicator of human life" after breathing, pulse, body temperature and blood pressure. Postoperative pain is an acute nociceptive pain caused by surgical trauma and is a complex stress response in the body, especially in 72 hours after surgery. Pain after thoracic surgery is a more severe type of surgery in various types of surgery.

Acute pain at the early stage of operation is not only an external signal of body injury, but also an independent factor inducing stress response and systemic inflammatory response syndrome (SIRS). Pain stimulus can also cause excessive release of catecholamine, damage of vascular endothelial cells and neutrophil aggregation, which can induce cytokine "waterfall" secretion. Stress, pain and inflammation induce and interact with each other, which seriously affects the early recovery of patients after operation. Timely and effective post-operative analgesia can not only alleviate patients'pain, but also avoid a series of stress reactions. It provides favorable conditions for the stability of patients' physiological function and recovery of their body after operation.

Although multimodal analgesia has largely replaced monotherapy with opioids, they are still the most commonly used drugs for postoperative pain. Lidocaine is an amide local anesthetic which when used intravenously demonstrates significant analgesic, anti-hyperalgesic and anti-inflammatory properties .

Intravenous infusion of lidocaine has a good effect on fibromyalgia, chronic neuropathic pain, opioid tolerance and other chronic pain, and can reduce postoperative acute pain. In the 1960s, Barlett et al. first published a study on the use of lidocaine intravenous infusion for postoperative analgesia.Since then, more and more researchers have begun to explore the use of lidocaine in the treatment of postoperative acute pain.In 2007, Kaba et al. selected patients who underwent colectomy as an experimental subject, and intravenously injected lidocaine during the perioperative period. The results showed that the pain of the experimental group was effectively relieved and the use of opioids was reduced. In 2008, Lauwick et al. used laparoscopic cholecystectomy as the experimental subject. The results showed that the dose of opioid analgesia in the lidocaine group was significantly lower than that in the control group, and the postoperative pain was effectively improved. In 2009, Yardeni et al. selected patients undergoing total hysterectomy as experimental subjects and intravenously injected lidocaine during the perioperative period. The results confirmed that the hemodynamics of the experimental group was more stable, the average dosage of anesthetics was reduced, and the pain was significantly improved.However, to date, there is no strong evidence for the effect of perioperative intravenous infusion of lidocaine in single-port thoracoscopic surgery, so we designed this study.

Tipo de estudo

Intervencional

Inscrição (Antecipado)

80

Estágio

  • Fase 4

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310009
        • Recrutamento
        • The Second Affiliated Hospital Zhejiang University School of Medicine
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 70 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Patients undergoing single-port thoracoscopic with a left double lumen bronchial catheter
  • Age ≧ 18 years old, ≦70 years old
  • Temperature, white blood cells, and hemoglobin were normal before surgery
  • Patient informed consent

Exclusion Criteria:

  • Patients with a history of surgery within six months
  • Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important organs
  • American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
  • Allergic to lidocaine
  • Bradycardia (heart rate < 60 beats/min) or atrioventricular block
  • Mental disorder
  • Patients requiring a right double lumen bronchial catheter

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Lidocaine group
First group (lidocaine group) will include those who receive a intraoperative lidocaine infusion.Induction bolus dose of 1.5 mg/kg body weight ( 30 minutes before incision)followed by a continous lidocaine infusion of 2mg/kg/h,until 1 hours after skin closure.
regimen of lidocaine administration of 1.5 mg/kg, IV bolus, followed by continuous infusion at 2 mg/kg/h
Comparador de Placebo: Saline group
The second group(saline group) will include those who receive a intraoperative placebo.The same dosage of saline was given according to the same method of administration in the lidocaine group.
IV bolus of saline, followed by continuous infusion of saline

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Postoperative pain score
Prazo: Immediately postoperation
Using Visual Analogue Scales
Immediately postoperation
Postoperative pain score
Prazo: 1 hour postoperation
Using Visual Analogue Scales
1 hour postoperation
Postoperative pain score
Prazo: 4 hours postoperation
Using Visual Analogue Scales
4 hours postoperation
Postoperative pain score
Prazo: 8 hours postoperation
Using Visual Analogue Scales
8 hours postoperation
Postoperative pain score
Prazo: 24 hours postoperation
Using Visual Analogue Scales
24 hours postoperation
Postoperative pain score
Prazo: 48 hours postoperation
Using Visual Analogue Scales
48 hours postoperation

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Opioid requirement
Prazo: Immediately postoperation
The dosage of opioids was recorded
Immediately postoperation
Opioid requirement
Prazo: 1 hour postoperation
The dosage of opioids was recorded
1 hour postoperation
Opioid requirement
Prazo: 4 hours postoperation
The dosage of opioids was recorded
4 hours postoperation
Opioid requirement
Prazo: 8 hours postoperation
The dosage of opioids was recorded
8 hours postoperation
Opioid requirement
Prazo: 24 hours postoperation
The dosage of opioids was recorded
24 hours postoperation
Opioid requirement
Prazo: 48 hours postoperation
The dosage of opioids was recorded
48 hours postoperation
Pressing times of PCIA postoperation
Prazo: 48 hours postoperation
The pressing times of PCIA within 48 hours postoperation was recorded
48 hours postoperation
Occurrence of nausea and/or vomiting
Prazo: 48 hours postoperation
The occurrence of nausea and vomiting within 48 hours postoperation was recorded
48 hours postoperation
Blood level of adrenaline
Prazo: before induction
Perioperative blood level of adrenaline was recorded
before induction
Blood level of adrenaline
Prazo: after incision
Perioperative blood level of adrenaline was recorded
after incision
Blood level of adrenaline
Prazo: immediately after extubation
Perioperative blood level of adrenaline was recorded
immediately after extubation
Blood level of norepinephrine
Prazo: before induction
Perioperative blood level of norepinephrine was recorded
before induction
Blood level of norepinephrine
Prazo: after incision
Perioperative blood level of norepinephrine was recorded
after incision
Blood level of norepinephrine
Prazo: immediately after extubation
Perioperative blood level of norepinephrine was recorded
immediately after extubation
Blood level of adrenocortical
Prazo: before induction
Perioperative blood level of adrenocortical was recorded
before induction
Blood level of adrenocortical
Prazo: after incision
Perioperative blood level of adrenocortical was recorded
after incision
Blood level of adrenocortical
Prazo: immediately after extubation
Perioperative blood level of adrenocortical was recorded
immediately after extubation
Blood level of TNF-alpha
Prazo: before induction
Perioperative blood level of TNF-alpha was recorded
before induction
Blood level of TNF-alpha
Prazo: after incision
Perioperative blood level of TNF-alpha was recorded
after incision
Blood level of TNF-alpha
Prazo: immediately after extubation
Perioperative blood level of TNF-alpha was recorded
immediately after extubation
Blood level of IL-6
Prazo: before induction
Perioperative blood level of IL-6 was recorded
before induction
Blood level of IL-6
Prazo: after incision
Perioperative blood level of IL-6 was recorded
after incision
Blood level of IL-6
Prazo: immediately after extubation
Perioperative blood level of IL-6 was recorded
immediately after extubation
Blood level of IL-10
Prazo: before induction
Perioperative blood level of IL-10 was recorded
before induction
Blood level of IL-10
Prazo: after incision
Perioperative blood level of IL-10 was recorded
after incision
Blood level of IL-10
Prazo: immediately after extubation
Perioperative blood level of IL-10 was recorded
immediately after extubation
Duration of hospital stay
Prazo: from day of surgery until day of discharge from hospital
length of hospital stay (in days)
from day of surgery until day of discharge from hospital

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Cadeira de estudo: Congcong Chen, Second Affiliated Hospital, School of Medicine, Zhejiang University

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Antecipado)

1 de agosto de 2019

Conclusão Primária (Antecipado)

31 de dezembro de 2019

Conclusão do estudo (Antecipado)

31 de dezembro de 2020

Datas de inscrição no estudo

Enviado pela primeira vez

19 de julho de 2019

Enviado pela primeira vez que atendeu aos critérios de CQ

31 de julho de 2019

Primeira postagem (Real)

2 de agosto de 2019

Atualizações de registro de estudo

Última Atualização Postada (Real)

2 de agosto de 2019

Última atualização enviada que atendeu aos critérios de controle de qualidade

31 de julho de 2019

Última verificação

1 de julho de 2019

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever